Episurf Medical Management
Management criteria checks 4/4
Episurf Medical's CEO is Pal Ryfors, appointed in Jun 2017, has a tenure of 7.17 years. total yearly compensation is SEK4.50M, comprised of 84.4% salary and 15.6% bonuses, including company stock and options. directly owns 0.46% of the company’s shares, worth SEK554.40K. The average tenure of the management team and the board of directors is 6.2 years and 8.3 years respectively.
Key information
Pal Ryfors
Chief executive officer
SEK 4.5m
Total compensation
CEO salary percentage | 84.4% |
CEO tenure | 7.2yrs |
CEO ownership | 0.5% |
Management average tenure | 6.2yrs |
Board average tenure | 8.3yrs |
Recent management updates
No updates
Recent updates
No updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -SEK 85m |
Mar 31 2024 | n/a | n/a | -SEK 92m |
Dec 31 2023 | SEK 5m | SEK 4m | -SEK 95m |
Sep 30 2023 | n/a | n/a | -SEK 97m |
Jun 30 2023 | n/a | n/a | -SEK 94m |
Mar 31 2023 | n/a | n/a | -SEK 84m |
Dec 31 2022 | SEK 5m | SEK 4m | -SEK 77m |
Sep 30 2022 | n/a | n/a | -SEK 72m |
Jun 30 2022 | n/a | n/a | -SEK 71m |
Mar 31 2022 | n/a | n/a | -SEK 69m |
Dec 31 2021 | SEK 4m | SEK 3m | -SEK 69m |
Sep 30 2021 | n/a | n/a | -SEK 67m |
Jun 30 2021 | n/a | n/a | -SEK 66m |
Mar 31 2021 | n/a | n/a | -SEK 63m |
Dec 31 2020 | SEK 4m | SEK 3m | -SEK 64m |
Sep 30 2020 | n/a | n/a | -SEK 66m |
Jun 30 2020 | n/a | n/a | -SEK 69m |
Mar 31 2020 | n/a | n/a | -SEK 73m |
Dec 31 2019 | SEK 2m | SEK 2m | -SEK 70m |
Sep 30 2019 | n/a | n/a | -SEK 66m |
Jun 30 2019 | n/a | n/a | -SEK 62m |
Mar 31 2019 | n/a | n/a | -SEK 59m |
Dec 31 2018 | SEK 2m | SEK 2m | -SEK 58m |
Sep 30 2018 | n/a | n/a | -SEK 58m |
Jun 30 2018 | n/a | n/a | -SEK 59m |
Mar 31 2018 | n/a | n/a | -SEK 55m |
Dec 31 2017 | SEK 2m | SEK 1m | -SEK 61m |
Compensation vs Market: Pal's total compensation ($USD439.01K) is about average for companies of similar size in the UK market ($USD369.14K).
Compensation vs Earnings: Pal's compensation has been consistent with company performance over the past year.
CEO
Pal Ryfors (41 yo)
7.2yrs
Tenure
SEK 4,500,000
Compensation
Mr. Pal Ryfors is Independent Director of Vivesto AB since May 2022. He serves as Chief Executive Officer of Episurf Medical AB (publ) since June 2, 2017 and served as its Acting Sales Director since 2021....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 7.2yrs | SEK 4.50m | 0.46% SEK 554.4k | |
Chief Financial Officer | 7.2yrs | no data | 0.017% SEK 20.7k | |
Chief Operating Officer | 5.2yrs | no data | 0.016% SEK 19.1k | |
Marketing Director | 7.6yrs | no data | 0.0041% SEK 4.9k | |
Head of QA & RA | less than a year | no data | no data | |
President of Episurf Medical Inc | 3yrs | no data | 0.041% SEK 49.5k |
6.2yrs
Average Tenure
43yo
Average Age
Experienced Management: EPISBS's management team is seasoned and experienced (6.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Chairman of the Board | 3.3yrs | SEK 400.00k | 0.058% SEK 70.4k | |
Independent Director | 3.3yrs | SEK 200.00k | 0.037% SEK 44.4k | |
Independent Director | 7.6yrs | SEK 200.00k | 0.12% SEK 147.8k | |
Member of Clinical Advisory Board & Director | 15.6yrs | SEK 800.00k | 0.090% SEK 107.8k | |
Member of Clinical Advisory Board | 8.8yrs | no data | no data | |
Member of Clinical Advisory Board | 8.8yrs | no data | no data | |
Member of Clinical Advisory Board | 8.8yrs | no data | no data | |
Member of Clinical Advisory Board | 8.8yrs | no data | no data | |
Independent Director | 8.3yrs | SEK 200.00k | 0.046% SEK 55.4k | |
Member of Clinical Advisory Board | 7.5yrs | no data | no data | |
Member of Clinical Advisory Board | 5.3yrs | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data |
8.3yrs
Average Tenure
67yo
Average Age
Experienced Board: EPISBS's board of directors are considered experienced (8.3 years average tenure).